Adragos Pharma is a globally operating Contract Development and Manufacturing Organisation (CDMO) headquartered in Germany. Adragos has three production sites in France, Germany, and Japan focusing on the production of FDF in the small-molecule segment. The sites cover relevant technologies in sterile and non-sterile liquids and semi-solids, providing end-to-end services for our large base of pharma customers.